Cafarotti, S. (2020). Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy. Journal of thoracic oncology, 15(7), e101-e103. https://doi.org/10.1016/j.jtho.2020.04.015
Chicago Style (17th ed.) CitationCafarotti, Stefano. "Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy." Journal of Thoracic Oncology 15, no. 7 (2020): e101-e103. https://doi.org/10.1016/j.jtho.2020.04.015.
MLA (9th ed.) CitationCafarotti, Stefano. "Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy." Journal of Thoracic Oncology, vol. 15, no. 7, 2020, pp. e101-e103, https://doi.org/10.1016/j.jtho.2020.04.015.